Working… Menu

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003425
Recruitment Status : Completed
First Posted : February 20, 2004
Last Update Posted : April 26, 2013
Information provided by (Responsible Party):
University of Kentucky